BMY
$57.48-0.63 (-1.08%)
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
Recent News
1 High-Yield Dividend Stock That's Too Cheap to Ignore
Sometimes "boring" is the way to go.
Will the Recent Label Expansion of BMY's Sotyktu Boost Its Prospects?
BMY's Sotyktu PsA approval boosts its immunology push, expands market reach, and sharpens its competitive stance amid pressure from legacy drug declines.
Top Stock Picks of 2026: Bristol-Myers Squibb
BMY has long-term support stepping up
Here is What to Know Beyond Why Bristol Myers Squibb Company (BMY) is a Trending Stock
Zacks.com users have recently been watching Bristol Myers (BMY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
These 3 Stocks Trigger Bearish Signals but 2 Offer Hidden Opportunity
A death cross forms when a stock’s 50-day moving average crosses below its 200-day moving average, signaling a potential downtrend. Right now, Bristol Myers Squibb (NYSE: BMY), FedEx (NYSE: FDX), and Ralph Lauren (NYSE: RL) are all flashing that signal. With the CBOE Volatility Index (VIX) at around 25, elevated macro uncertainty is clustering these ... These 3 Stocks Trigger Bearish Signals but 2 Offer Hidden Opportunity